These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prospective evaluation of pretreatment executive cognitive impairment and depression in patients referred for radiotherapy. Fuller CD; Schillerstrom JE; Jones WE; Boersma M; Royall DR; Fuss M Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):529-33. PubMed ID: 18411001 [TBL] [Abstract][Full Text] [Related]
8. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Blackstone K; Moore DJ; Franklin DR; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; Ellis RJ; Atkinson JH; Grant I; Heaton RK Clin Neuropsychol; 2012; 26(6):894-908. PubMed ID: 22708483 [TBL] [Abstract][Full Text] [Related]
9. Identifying early diffusion imaging biomarkers of regional white matter injury as indicators of executive function decline following brain radiotherapy: A prospective clinical trial in primary brain tumor patients. Tringale KR; Nguyen T; Bahrami N; Marshall DC; Leyden KM; Karunamuni R; Seibert TM; Kay Gorman M; Connor M; Burkeen J; Piccioni DE; Farid N; Hattangadi-Gluth JA; McDonald CR Radiother Oncol; 2019 Mar; 132():27-33. PubMed ID: 30825966 [TBL] [Abstract][Full Text] [Related]
10. An examination of the neurocognitive profile and base rate of performance impairment in primary dystonia. Niccolai L; Aita SL; Walker HC; Martin RC; Clay OJ; Crowe M; Triebel KL J Clin Neurosci; 2020 Apr; 74():1-5. PubMed ID: 31932183 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study. Jia P; Zhao Z; Hulgan T; Bush WS; Samuels DC; Bloss CS; Heaton RK; Ellis RJ; Schork N; Marra CM; Collier AC; Clifford DB; Gelman BB; Sacktor N; Morgello S; Simpson DM; McCutchan JA; Barnholtz-Sloan JS; Franklin DR; Rosario D; Letendre SL; Grant I; Kallianpur AR; Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):413-426. PubMed ID: 28447399 [TBL] [Abstract][Full Text] [Related]
12. Neuropsychological performances in patients with infiltrative non-GBM gliomas after postoperative adjuvant photon or proton radiotherapy: A prospective and preliminary investigation. Lin SY; Chuang CC; Huang YC; Pai PC; Lee CC; Wei KC; Tseng CK; Yang CC Appl Neuropsychol Adult; 2024; 31(4):606-615. PubMed ID: 35343323 [TBL] [Abstract][Full Text] [Related]
13. Neurocognitive status in patients with newly-diagnosed brain tumors in good neurological condition: The impact of tumor type, volume, and location. Hendrix P; Hans E; Griessenauer CJ; Simgen A; Oertel J; Karbach J Clin Neurol Neurosurg; 2017 May; 156():55-62. PubMed ID: 28334687 [TBL] [Abstract][Full Text] [Related]
15. Neurocognitive predictors of length of stay within a children's psychiatric inpatient program. Kavanaugh B; Studeny J; Cancilliere MK; Holler KA Child Neuropsychol; 2020 Jan; 26(1):129-136. PubMed ID: 31094643 [TBL] [Abstract][Full Text] [Related]
16. Acute neurocognitive impairment during cranial radiation therapy in patients with intracranial tumors. Welzel G; Fleckenstein K; Mai SK; Hermann B; Kraus-Tiefenbacher U; Wenz F Strahlenther Onkol; 2008 Dec; 184(12):647-54. PubMed ID: 19107345 [TBL] [Abstract][Full Text] [Related]
17. Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study. Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ BMC Infect Dis; 2012 Feb; 12():39. PubMed ID: 22335937 [TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in primary brain tumors outpatients: a prospective cross-sectional survey. Zucchella C; Bartolo M; Di Lorenzo C; Villani V; Pace A J Neurooncol; 2013 May; 112(3):455-60. PubMed ID: 23417320 [TBL] [Abstract][Full Text] [Related]
19. Trajectories of psychosocial and cognitive functioning in pediatric patients with brain tumors treated with radiation therapy. Willard VW; Berlin KS; Conklin HM; Merchant TE Neuro Oncol; 2019 May; 21(5):678-685. PubMed ID: 30624746 [TBL] [Abstract][Full Text] [Related]
20. Multi-domain neurocognitive impairment following definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A cross-sectional study. Chow JCH; Lee J; Lai MMP; Li S; Lau AMC; Ng BSY; Leung GGG; Li STY; Lui JCF; Cheung KM; Au KH; Wong KH; Lau AYL; Zee BCY Radiother Oncol; 2024 Apr; 193():110143. PubMed ID: 38341098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]